Answers are grounded in this paper and cite their sources.
Purpose Patients with hypoparathyroidism have an increased risk of nephrolithiasis and chronic kidney disease. Hypercalciuria is a key risk factor that requires periodic monitoring. While 24-hour urinary calcium (24hUCa) is the gold standard, its cumbersome nature limits frequent testing. This study evaluates the utility of the spot urine calcium-to-creatinine ratio (UCa/UCr) for detecting hypercalciuria in these patients. Methods A descriptive cross-sectional study was conducted with 14 subjects (12 post-surgical) treated with calcitriol and calcium carbonate, without thiazides. Participants provided a 24-hour urine sample and a fasting spot urine sample. Hypercalciuria was defined as > 250 mg/24h in women and > 300 mg/24h in men. Results Four subjects presented with hypercalciuria. UCa/UCr was significantly higher in hypercalciuric patients (0.254 vs. 0.136 mg/mg; p=0.036) and showed a positive correlation with 24hUCa (Spearman's rho: 0.701; p=0.005). The optimal UCa/UCr cutoff was 0.142 mg/mg (Youden method), with an AUC of 0.875. At this cutoff, UCa/UCr demonstrated a sensitivity of 1, specificity of 0.7, negative predictive value (NPV) of 1, and positive predictive value (PPV) of 0.57. Conclusions UCa/UCr is a useful screening method for hypercalciuria in hypoparathyroidism, specifically for ruling out the condition given its high NPV. While promising for routine clinical monitoring, validation in larger cohorts is necessary.
No takes yet. Share an insight, caveat, or question.
Capel et al. (2026) studied this question.